Request for Partnership 2025 The Australian Venom Innovation and Discovery (AVID) Initiative is pleased to announce that the 2025 Request for Partnership is now open! Initiative background Australia is home to one of the world’s most diverse ranges of venomous and...
Australia harbours one of the world’s richest diversities of venomous species, from spiders and snakes to marine organisms and insects. Venoms play critical ecological roles, helping species hunt, defend themselves, and adapt to their environments. They also...
Bioplatforms Australia congratulates all the winners of the 2025 Australian Museum Eureka Prizes, announced on 3 September at the Australian Museum in Sydney. Now in its 35th year, the Eureka Prizes recognise the very best in Australian science, spanning research,...
Bioplatforms Australia is proud to partner with Therapeutic Innovation Australia (TIA), Phenomics Australia, and ANSTO to support translational medical research through the Pipeline Accelerator voucher scheme. The initiative, launched by TIA, tackles the medical...
Illicit drug use poses a growing public health challenge, with increasingly potent and unpredictable substances circulating in the community. In recent years, new synthetic drugs and dangerous drug mixtures have become more common, increasing the risk of overdose and...
Australian researchers have achieved the most promising advance in brain cancer treatment in two decades, with a new clinical trial showing that a targeted drug can shrink previously incurable tumours by up to 90 per cent. As reported by Natasha Robinson in The...
